Temporal trends of a vasopressin V2 receptor antagonist in heart failure using a nationwide database in Japan

ConclusionsThis large ‐scale survey indicated an increased rate of tolvaptan prescription and an early shift to tolvaptan treatment in patients with HF in Japan. The prognostic effects of this change in HF treatment remain unclear.

Source: ESC Heart Failure - November 12, 2020 Category: Cardiology Authors: Takashi Kuragaichi, Yukihito Sato Tags: Original Research Article Source Type: research